Group 1 - The core viewpoint of the news is that Hengtong Holdings has shown significant stock performance, with a year-to-date increase of 103.92% and a recent rise of 2.16% in stock price [1] - As of December 25, the stock price reached 5.20 yuan per share, with a total market capitalization of 15.467 billion yuan [1] - The company has experienced a net inflow of main funds amounting to 9.6066 million yuan, with large orders contributing significantly to the trading volume [1] Group 2 - Hengtong Holdings, established on May 11, 1999, primarily engages in the production and sales of biopesticides, veterinary drugs, and feed additives, with a revenue composition of 67.62% from electrolytic copper foil [2] - As of September 30, 2025, the company reported a revenue of 1.262 billion yuan, reflecting a year-on-year growth of 38.94%, and a net profit attributable to shareholders of 189 million yuan, with a slight increase of 0.68% [2] - The company has a total of 51,800 shareholders as of September 30, 2025, which is an increase of 51.38% from the previous period [2] Group 3 - Hengtong Holdings has cumulatively distributed 709 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the eighth largest shareholder, holding 21.294 million shares as a new investor [3]
亨通股份涨2.16%,成交额2.38亿元,主力资金净流入960.66万元